Lucía López‐Anglada

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva, Noemí Puig, María‐Teresa Cedena et al. · Journal of Clinical Oncology · 2019 · 261 citations · Full text

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

Laura Rosiñol, Albert Oriol, Rafael Ríos et al. · Blood · 2019 · 207 citations · Full text

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Jorge Labrador, Lucía López‐Anglada, Estefanía Pérez‐López et al. · Haematologica · 2012 · 86 citations · Full text

Significant Clinical Bleeding, Thrombosis, Venous Thrombosis +18

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality

Joaquín Martínez‐López, Bruno Paiva, Lucía López‐Anglada et al. · Blood · 2015 · 61 citations · Full text

<i>P53</i> deletion may drive the clinical evolution and treatment response in multiple myeloma

Lucía López‐Anglada, Norma C. Gutiérrez, María‐Victoria Mateos et al. · European Journal Of Haematology · 2009 · 53 citations